Entrepreneurship
School of Pharmacy
The School of Pharmacy is driving a new era of discovery, where breakthrough science is transformed into real-world applications with far-reaching impact. From chronic diseases to cancer to neurodegeneration, our faculty, graduate students, and postdoctoral scholars are pioneering technologies and therapies that reshape how we address the world’s most pressing health challenges.
With more than 44 faculty-founded startups, 192 invention disclosures, and 64 patents issued, we are a leader in the nation’s academic entrepreneurship. Our Researchers are advancing novel drug candidates and innovative approaches that can be optimized for clinical trials, accelerating the long journey from discovery to treatment with the greatest chance of success. Many groups within the UCSF School of Pharmacy help move these innovations beyond the lab, guiding our community through the complex path of technology development and commercialization.
From identifying promising drug candidates and securing funding to building external partnerships and launching new companies, our collaborative innovation ecosystem gives researchers and trainees the support, knowledge, and connections needed to bring life-changing therapies closer to the patients who need them most.
Faculty Founded Startups
44
Invention Disclosures
192
Patents Issued
64
Leadership
-
Michelle Arkin, PhD
Vice Dean of Research Technology and Entrepreneurship
Learn more about Michelle Arkin, PhDMy research focuses on the development of drug-like molecules that alter important biological processes. These molecules will help us understand human biology and may lead to the design of new drugs. I also chair the Department of Pharmaceutical Chemistry. Details: Administration.
-
Adam Renslo, PhD
Professor
Learn more about Adam Renslo, PhDI am the School’s representative in collaborations between our academic scientists and industry, aiming to translate the most promising discoveries and technologies from our research into therapies that reach patients.
My research group is engaged at the interface of chemistry and biology.…
Companies founded
A sampling of Companies, built on our expertise, linked to profile or company of founders.
All product and company names are trademarks or registered trademarks of their respective holders.
-
Pam England
153TX
-
Michelle Arkin, PhD
Ambagon Therapeutics
-
Matt Jacobson, PhD
Calithera
-
Matt Jacobson, PhD
Cedilla Therapeutics
-
Matt Jacobson, PhD
Circle Pharma
-
Aashish Manglik, MD, PhD
Ab Initio BioTherapeutics
-
Jason Gestwicki, PhD
Amplyx Pharmaceuticals
Now owned by Pfizer
-
Les Benet, PhD
Avlan
-
Les Benet, PhD
Avmax
-
Su Guo
Cerepeut, Inc.
-
Michelle Arkin, PhD and Adam Renslo, PhD
Elgia Therapeutics
-
Lei Wang
Enlaza Therapeutics
-
Lei Wang
Entwine Bio
-
Jim Wells
Epi Biologics
-
Aashish Manglik and Brian Shiochet
Epiodyne
-
Michael Grabe, Phd
Equator Therapeutics
-
Tanja Kortemme
Evercrisp
-
Matt Jacobson
GBT Hope + Science + Community
-
Les Benet
Hurel Corp
Now owned by Visikol
-
Jason Gestwicki
Kaizen Therapeutics
-
matt Jacobson
Nine Square
-
Les Benet, PhD
OxoN Medica
-
Bo Huang, Phd
Polariton Life
-
Zev, Gartner, PhD
Provenance Bio
-
Aashish Manglik, MD, PhD
Septerna
-
Shuvo Roy, Phd
Silicon Kidney
-
Les Benet, PhD
Squal Pharma
-
Aashish Manglik, MD, PhD
Stipple bio
-
Jim Wells, PhD
Sunesis Pharmaceuticals
Now owned by Viracta
-
Michelle Arkin, PhD
Taspase1 incubator with Autobahn
-
Adam Renslo, PhD
Tatara Therapeutics
-
Matt Jacobson, PhD
Terremoto
-
Adam Renslo, PhD
TheRas, Inc.
-
Jason Gestwicki, PhD
Viewpoint Therapeutics
Now owned by Visus